SCHEMBL17437565

SCHEMBL17437565

CCn1c(-n2ncnc2N)nc2cncc(-c3ccc(F)cc3C)c21

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 1/20 0.35
CYP11B1 P15538 2/20 0.34
CYP11B2 P19099 2/20 0.34
RPS6KA5 O75582 5/20 0.34
GRM5 P41594 3/20 0.32
TLR7 Q9NYK1 1/20 0.32
GRIN1 Q05586 2/20 0.30
GRIN2B Q13224 2/20 0.30
KDM4E B2RXH2 1/20 0.30
MAPT P10636 1/20 0.30
MAPK1 P28482 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
SIGMAR1 Q99720 1/20 0.30
CYP17A1 P05093 1/20 0.30
CYP1A2 P05177 1/20 0.30
PDE10A Q9Y233 2/20 0.30
SOS1 Q07889 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17437395 0.92 DPP4 (0.36) CYP11B1CYP11B2RPS6KA5TLR7KDM4E
SCHEMBL17437538 0.91 CYP11B1 (0.34) CYP11B1CYP11B2RPS6KA5TLR7GRIN2B
SCHEMBL17437322 0.90 TLR8 (0.33) TLR8RPS6KA5
SCHEMBL17437455 0.89 CYP17A1 (0.34) CYP11B1CYP11B2RPS6KA5CYP17A1CYP1A2
SCHEMBL17437452 0.88 GRM5 (0.35) GRM5GRIN1GRIN2BSIGMAR1
SCHEMBL17437441 0.86 NPC1 (0.32) TLR8CYP11B1CYP11B2RPS6KA5KDM4E
SCHEMBL16053847 0.86 RPS6KA5 (0.36) TLR8RPS6KA5CYP1A2
SCHEMBL17437589 0.86 RPS6KA5 (0.31) CYP11B2RPS6KA5GRIN1GRIN2B
SCHEMBL17437388 0.84 EGLN2 (0.34) CYP11B1CYP11B2GRIN2BMAPTL3MBTL1
SCHEMBL17437397 0.84 GRIN2B (0.32) CYP11B1CYP11B2RPS6KA5TLR7GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2017-02-23 US disclosed
US-9512120-B2 Microbicidally active imidazopyridine derivatives SYNGENTA PARTICIPATIONS AG (CH) 2016-12-06 US disclosed
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2016-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 TLR8 382/4885CYP11B1 1360/4885CYP11B2 1464/4885
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 TLR8 382/4885CYP11B1 1360/4885CYP11B2 1464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.